New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

Value, Pricing, and Access in the New Healthcare Landscape 04/14/2022
Balancing Market Access and Regulatory Requirements 02/14/2022
Value & Outcomes Spotlight: Using RWE/RWD to Drive Health Policy 04/05/2022
Tufts Medical Center and National Health Council Report New… 05/25/2021
Preparing for High Stakes Meetings; How to Best Convey a New… 06/18/2021
Syntropy and UCI Unite in 5-Year RWD Collaboration to Improve… 10/13/2021
Parexel and Kyoto University Hospital Announce Strategic… 10/28/2021